FindTrial
Sign In

Endothelial cell dysfunction is involved in acute coronary syndrome (ACS).Therapy includes antiplatelet, thrombus removal by drugs or intervention. Normal endothelium has antiplatelet and fibrinolytic property.This study focuses upon improving endothelial cells functioning in (ACS).

ENDOTHELIAL CELLS STRENGTHENING: IMPROVING FUNCTIONS IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/07/009125
Enrollment
200
Registered
2017-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Acute coronary syndrome

Interventions

Intervention1: administration of triphala powder: Intervention-group1- Clopidogrel 150mg + aspirin 150mg stat± subjected to thrombolysis /CAG according to requirement . Group2 Clopidogrel 150mg + asp

Sponsors

Mittal hospital and Research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria- Cases coming with chest pain typical of coronary artery disease with ECG changes suggestive of myocardial ischemia/infarction

Exclusion criteria

Exclusion criteria: Exclusion criteria- Patient coming with severe breathlessness, shock, any degree of block/ arrhythmia in ECG/past history of cerebrovascular accident

Design outcomes

Primary

MeasureTime frame
a) relief in chest pain b)Improvement in ECG changes Timepoint: 30 minutes—

Secondary

MeasureTime frame
Improvement suggested by Echocardiography,reduction in requirement of thrombolysis,reduction in coronary angiography requirementTimepoint: 30 minutes to 48 hours—

Countries

India

Contacts

Public ContactDr Tarun Saxena

Mittal Hospital and Research Center Pushkar Road Ajmer

yogdiab@gmail.com9829089284

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026